Arrowhead Pharmaceuticals
ARWR
#2161
Rank
HK$70.23 B
Marketcap
HK$501.56
Share price
-0.11%
Change (1 day)
264.13%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -HK$9.83

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$9.76. an increase over its 2024 EPS that were of -HK$39.03.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025-HK$0.07805-99.8%
2024-HK$39.03161.39%
2023-HK$14.9317.36%
2022-HK$12.7219.85%
2021-HK$10.6261.9%
2020-HK$6.56-216.67%
2019HK$5.62-210.77%
2018-HK$5.0738.3%
2017-HK$3.67-64.93%
2016-HK$10.46-16.25%
2015-HK$12.4928%
2014-HK$9.76-3.85%
2013-HK$10.15-31.58%
2012-HK$14.83331.82%
2011-HK$3.43-51.11%
2010-HK$7.02-79.07%
2009-HK$33.56-37.68%
2008-HK$53.86-16.87%
2007-HK$64.7838.33%
2006-HK$46.83122.22%
2005-HK$21.0742.11%
2004-HK$14.83533.33%
2003-HK$2.34-99.08%
2002-HK$253.4125%
2001-HK$202.7333.33%
2000-HK$152.05-120%
1999HK$760.24-400%
1998-HK$253.41-81.48%
1997-HK$1,368

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$86.93-990.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$62.99 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$18.65-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$0.70-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$22.48 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA